Indian Patent Office Clears Nexavar/Sorafenib for Generic Licensing
The compound with the structure below is a Bayer' patented anticancer drug for renal and liver cancer, marketed as Nexavar.
Author: Dr RC Mishra
2011 Impact Factor List of Organic & Medicinal Chemistry Journals
The 2011 list of Journal Impact Factor for Organic and Medicinal Chemistry Journals is embedded below you can download the same by opening…
Endnote X6 Beta is here for testing!
Thomson Reutor's latest bibliographic tool is here for people using Mac. We are looking for current EndNote for Mac users to beta test…
Chemistry Nobel 2012, October 10th Live from Stockholm
The Winners of Noble Prize in Chemistry are being announced at 11:45 AM CET (Central European Time) on Wednesday, 10th October 2012. The prize…
Centrosome Declustering: An Anticancer Strategy
Centrosome clustering is a phenomenon associated with tumorigenesis. The clustering of centrosomes in cancer cells enables them to form a pseudo-bipolar mitotic spindle.…
Bosutinib – Bosulif approved for Leukemia by Pfizer
A new anticancer drug for Leukemia has been approved by FDA. The drug treats chronic myelogenous leukemia (CML), a blood and bone marrow…
Co-First Authors & Bibliography
Just saw this in the editorial comment section of the journal Gastroenterology. What they say is that they are going to introduce the…